BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7513604)

  • 1. Clinical and biologic characteristics of CD7+ acute myeloid leukemia. Our experience and literature review.
    Shimamoto T; Ohyashiki JH; Ohyashiki K; Kawakubo K; Inatomi Y; Fujieda H; Nakazawa S; Kimura N; Miyauchi J; Toyama K
    Cancer Genet Cytogenet; 1994 Mar; 73(1):69-74. PubMed ID: 7513604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological characteristics of CD7 positive acute myelogenous leukaemia.
    Eto T; Akashi K; Harada M; Shibuya T; Takamatsu Y; Teshima T; Niho Y
    Br J Haematol; 1992 Nov; 82(3):508-14. PubMed ID: 1283077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human granulocyte colony-stimulating factor receptors in acute myelogenous leukemia.
    Kondo S; Okamura S; Asano Y; Harada M; Niho Y
    Eur J Haematol; 1991 Apr; 46(4):223-30. PubMed ID: 1707827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD7-positive acute myeloid leukemia: further evidence of cellular immaturity.
    Kondo S; Okamura S; Harada N; Ikematsu W; Kawasaki C; Fukuda T; Kubota A; Shimoda K; Harada M; Shibuya T
    J Cancer Res Clin Oncol; 1992; 118(5):386-8. PubMed ID: 1374757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A subset of acute nonlymphocytic leukemia with expression of surface antigen CD7--morphologic, cytochemical, immunocytochemical and T cell receptor gene analysis on 13 patients.
    Tien HF; Wang CH; Su IJ; Liu FS; Wu HS; Chen YC; Lin KH; Lee SC; Shen MC
    Leuk Res; 1990; 14(6):515-23. PubMed ID: 1695699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of MDR1 gene in acute leukemia cells: association with CD7+ acute myeloblastic leukemia/acute lymphoblastic leukemia.
    Miwa H; Kita K; Nishii K; Morita N; Takakura N; Ohishi K; Mahmud N; Kageyama S; Fukumoto M; Shirakawa S
    Blood; 1993 Dec; 82(11):3445-51. PubMed ID: 7694687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of lymphocyte surface markers in acute myeloid leukemia.
    Ball ED; Davis RB; Griffin JD; Mayer RJ; Davey FR; Arthur DC; Wurster-Hill D; Noll W; Elghetany MT; Allen SL
    Blood; 1991 May; 77(10):2242-50. PubMed ID: 1709379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of acute myeloid leukemia (AML) coexpressing lymphoid markers: different biologic features between T-cell antigen positive and B-cell antigen positive AML.
    Tien HF; Wang CH; Chen YC; Shen MC; Lin DT; Lin KH
    Leukemia; 1993 May; 7(5):688-95. PubMed ID: 8483320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical importance of CD7 expression in acute myelocytic leukemia. The Japan Cooperative Group of Leukemia/Lymphoma.
    Kita K; Miwa H; Nakase K; Kawakami K; Kobayashi T; Shirakawa S; Tanaka I; Ohta C; Tsutani H; Oguma S
    Blood; 1993 May; 81(9):2399-405. PubMed ID: 7683218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD7 expression in acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Cox C; Aronica G; Masi M; Bruno A; Simone MD; Buccisano F; Papa G
    Leuk Lymphoma; 1995 Mar; 17(1-2):111-9. PubMed ID: 7539657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between immunogenotypic findings in de novo AML and AML post MDS.
    Ohyashiki JH; Ohyashiki K; Kawakubo K; Fujimura T; Shimamoto T; Nakazawa S; Kimura N; Toyama K
    Leukemia; 1993 Nov; 7(11):1747-51. PubMed ID: 7694003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD7+ acute non-lymphocytic leukemia: evidence for an early multipotential progenitor.
    Zutter MM; Martin PJ; Hanke D; Kidd PG
    Leuk Res; 1990; 14(1):23-6. PubMed ID: 1689436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of CD7-positive stem cell leukemia. A distinct subtype of mixed lineage leukemia.
    Yumura-Yagi K; Hara J; Kurahashi H; Okamura J; Koizumi S; Toyoda Y; Murayama N; Inoue M; Ishihara S; Tawa A
    Cancer; 1991 Nov; 68(10):2273-80. PubMed ID: 1717122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic and clinical significance of CD7 expression in acute myeloid leukemia.
    Saxena A; Sheridan DP; Card RT; McPeek AM; Mewdell CC; Skinnider LF
    Am J Hematol; 1998 Aug; 58(4):278-84. PubMed ID: 9692390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of T cell receptor D delta 2(D delta)J delta rearrangement in CD7-positive early T cell acute lymphoblastic leukemia.
    Kimura N; Akiyoshi T; Uchida T; Okamura J; Kozuru M; Nishimura J; Ohyashiki JH; Kikuchi M; Niho Y; Okumura M
    Leukemia; 1996 Apr; 10(4):650-7. PubMed ID: 8618442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Configuration of immunoglobulin and T cell receptor beta and gamma genes in acute myeloid leukaemia: pitfalls in the analysis of 40 cases.
    Parreira L; Carvalho C; Moura H; Melo A; Santos P; Guimarães JE; Parreira A
    J Clin Pathol; 1992 Mar; 45(3):193-200. PubMed ID: 1372916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terminal deoxynucleotidyl transferase and CD7 expression in acute myeloid leukemias are not associated with a high frequency of immunoglobulin and/or T cell receptor gene rearrangement.
    Willière G; Stockinger H; Köller U; Majdic O; Schnabl E; Lutz D; Bettelheim P; Knapp W
    Leukemia; 1990 Apr; 4(4):278-81. PubMed ID: 1694941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD7 positive acute myeloid leukaemia: a subtype associated with cell immaturity.
    Lo Coco F; De Rossi G; Pasqualetti D; Lopez M; Diverio D; Latagliata R; Fenu S; Mandelli F
    Br J Haematol; 1989 Dec; 73(4):480-5. PubMed ID: 2482063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytokine in phenotypic analysis of leukemia/lymphoma: suppression of gene expression of myeloperoxidase by IFN-gamma and subset of AML M1 defined by CD45RO+/RA-, CD7(-), CD34(-) and non-inducible HLA-DR antigen].
    Tatsumi E; Yoneda N; Kawano S; Yamaguchi N
    Rinsho Byori; 1993 Apr; 41(4):377-83. PubMed ID: 7688832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.